Menu
episode 43
In Episode 43, I talk to Alan Oppenheim, CEO of Ego Pharmaceuticals, an Australian company that exists to improve people’s lives through the science of healthy skin and sells its products around the world including the Middle East, Asia Pacific and the UK.
Ego has won numerous awards for it performance in the export space and it is one of Australia’s great international success stories.
Join Alan and I as we talk about:
… and much more.
This is an episode with loads of value for anyone working with physical products, especially in the consumer space. Alan is generous with his insights and very easy to listen to.
I hope you enjoy our conversation – it was a pleasure to record.
Let us know that you’d like to learn more about how we work and a member of our team will be in touch to book an introductory call.
Dearin & Associates is an international strategy consulting firm that advises companies on international expansion, marketing research and modelling, cross-cultural training and strategic business connections.
Dearin & Associates’ Payment and Foreign Currency Exchange Services are provided by Ebury Partners UK Limited. Ebury Partners UK Limited is registered with the Australian Securities and Investments Commission (ASIC), Australian Registered Body (ARBN:625009887) and with the Australian Transaction Reports and Analysis Centre (AUSTRAC). Ebury provides financial services in Australia pursuant to a licensing Exemption provided by the Australian Securities and Investments Commission (ASIC).
Dearin & Associates is a trading name of Classline Pty Ltd, a company registered in Australia (registered no. ABN 76 071 530 311). Registered office: Suite 2, Level 10,234 George St, NSW 2000.
We’re excited to hear that you’re considering going global. Tell us a bit about your international expansion goals and a member of our team will get in touch.
This website uses cookies to enhance your browsing experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.
Keep in touch!
Get the latest insights into international market entry.